Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7033877 and colistin methanesulfonate sodium drug-drug interaction study in healthy volunteers
NL-OMON41756Active, not recruiting
- Sponsor
- Roche
- Start
- Jul 2014
- Modality
- Small Molecules, Modified Peptides → Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of murepavadin and colistimethate sodium in pneumonia and Infection (2 arms), sponsored by Roche. Primary endpoint: Pharmacokinetic drug-drug interaction between RO7033877 and colistin methanesulfonate sodium. Started Jul 2014; status: active, not recruiting.
02
Drugs
murepavadincolistimethate sodium
03
Conditions
pneumoniaInfection
Beyond the preview
Go deeper on NL-OMON41756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41756.